Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Desmopressin for nocturnal enuresis in pediatric sickle cell disease
NCT04420585Phase 4Terminated
- Sponsor
- Montefiore Medical Center
- Start
- Jul 2020
- Primary completion
- Jun 2023
- Modality
- Peptides, Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of desmopressin in nocturnal enuresis (NE), sponsored by Montefiore Medical Center. Started Jul 2020; status: terminated.
02
Drugs
desmopressin
03
Conditions
nocturnal enuresis (NE)
Beyond the preview
Go deeper on NCT04420585.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04420585.